UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the die has not been cast

Annals of oncology, 2022-06, Vol.33 (6), p.658-659

2022

Volltextzugriff (PDF)

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

Head & neck, 2005-10, Vol.27 (10), p.843-850

2005

Volltextzugriff (PDF)

394 INVITED Is It Time to Review the Common Toxicity Criteria in the Era of New Targeted Drugs?

European journal of cancer (1990), 2011, Vol.47, p.S86-S86

Jassem, J

2011

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) inhibitors and derived treatments

Annals of oncology, 2012-09, Vol.23 Suppl 10, p.x193-x196

2012

Volltextzugriff (PDF)

Post-mastectomy radiation therapy after breast reconstruction: indication, timing and results

Breast (Edinburgh), 2017-03, Vol.32, p.S16-S17

2017

Volltextzugriff (PDF)

ES20.01 Tobacco Cessation After Cancer Diagnosis: Declaration from IASLC

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S61-S61

Jassem, J.

2019

Volltextzugriff (PDF)

MS24.03 The Importance of Physician Involvement in Tobacco Control

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S292-S292

Jassem, J.

2018

Volltextzugriff (PDF)

The European Code of Cancer Practice

Journal of cancer policy, 2021-06, Vol.28, p.100282-100282, Article 100282

2021

Volltextzugriff (PDF)

MTE 25.01 Smoking after Diagnosis of Cancer

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1653-S1654

Jassem, J.

2017

Volltextzugriff (PDF)

IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC

Annals of oncology, 2019-10, Vol.30, p.v915

2019

Volltextzugriff (PDF)

SP-0416 COMBINED MODALITIES INCLUDING CHEMORADIATION AND MOLECULAR TARGETING

Radiotherapy and oncology, 2012-05, Vol.103, p.S166-S166

2012

Volltextzugriff (PDF)

1236P Feasibility of online symptom monitoring to detect lung cancer relapse in Poland

Annals of oncology, 2023-10, Vol.34, p.S722-S722

2023

Volltextzugriff (PDF)

Assessing the Burden of Caregiving for Patients with Lung Cancer in Europe

Value in health, 2013-11, Vol.16 (7), p.A403-A403

2013

Volltextzugriff (PDF)

1609 Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)

European journal of cancer (1990), 2015-09, Vol.51, p.S241-S241

2015

Volltextzugriff (PDF)

Third CECOG consensus on the systemic treatment of non-small-cell lung cancer

Annals of oncology, 2012-05, Vol.23 (5), p.1223-1229

2012

Volltextzugriff (PDF)

Second consensus on medical treatment of metastatic breast cancer

Annals of oncology, 2007-02, Vol.18 (2), p.215-225

2007

Volltextzugriff (PDF)

48. MicroRNA prognostic signature for distant relapse in early stage colon cancer

European journal of surgical oncology, 2016-09, Vol.42 (9), p.S85-S85

2016

Volltextzugriff (PDF)

3099 Phase 3 trial (NGR015) of best investigator choice (BIC) with or without NGR-hTNF in previously treated malignant pleural mesothelioma (MPM)

European journal of cancer (1990), 2015-09, Vol.51, p.S634-S634

2015

Volltextzugriff (PDF)

484 Germline Variants in Angiogenesis Genes as Markers of Progression-free Survival in Stage I-III Non-small Cell Lung Cancer Patients

European journal of cancer (1990), 2012-11, Vol.48, p.150-150

2012

Volltextzugriff (PDF)

PO-1324 Body composition as a predictor of an in-field recurrence in stage III NSCLC patients

Radiotherapy and oncology, 2023-05, Vol.182, p.S1059-S1060

2023

Volltextzugriff (PDF)

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

The New England journal of medicine, 2012-09, Vol.367 (13), p.1187-1197

2012

Volltextzugriff (PDF)

AOSOP6 Results from the 2-year open-label extension treatment phase of a pivotal phase 3 study of denosumab in patients with breast cancer and bone metastases previously treated with zoledronic acid or denosumab

European journal of cancer (1990), 2012-04, Vol.48, p.S3-S3

2012

Volltextzugriff (PDF)

SA 8.4 - Post-mastectomy radiation therapy after breast reconstruction: indication, timing and results

Breast (Edinburgh), 2017-03, Vol.32, p.S16-S17

2017

Volltextzugriff (PDF)

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Annals of oncology, 2019-07, Vol.30 (7), p.1181-1181

2019

Volltextzugriff (PDF)

Phase III trial (EORTC 10994/BIG 00-01) assessing the value of p53 using a functional assay to predict sensitivity to a taxane versus nontaxane primary chemotherapy in breast cancer: Final analysis

JOURNAL OF CLINICAL ONCOLOGY, 2010, Vol.28 (18_suppl), p.LBA503-LBA503

2010

Volltextzugriff (PDF)

1 – 25 von 533

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(490)
Mit Volltextzugriff
(467)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(153)
Life Sciences & Biomedicine
(115)
Humans
(93)
Oncology
(64)
Biological And Medical Sciences
(30)
Medical Sciences
(29)
Physical Sciences
(29)
Hematology, Oncology And Palliative Medicine
(24)
Medicin Och Hälsovetenskap
(22)
Respiratory System
(22)
Physics
(20)
Chemotherapy
(15)
Immunology
(15)
Lung Neoplasms - Pathology
(15)
Adult
(14)
Male
(14)
Carcinoma, Non-Small-Cell Lung - Pathology
(13)
Technology
(13)
Pharmacology. Drug Treatments
(12)
Antineoplastic Agents
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the die has not been cast

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

394 INVITED Is It Time to Review the Common Toxicity Criteria in the Era of New Targeted Drugs?

Epidermal growth factor receptor (EGFR) inhibitors and derived treatments

Post-mastectomy radiation therapy after breast reconstruction: indication, timing and results

ES20.01 Tobacco Cessation After Cancer Diagnosis: Declaration from IASLC

MS24.03 The Importance of Physician Involvement in Tobacco Control

The European Code of Cancer Practice

MTE 25.01 Smoking after Diagnosis of Cancer

IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC

SP-0416 COMBINED MODALITIES INCLUDING CHEMORADIATION AND MOLECULAR TARGETING

1236P Feasibility of online symptom monitoring to detect lung cancer relapse in Poland

Assessing the Burden of Caregiving for Patients with Lung Cancer in Europe

1609 Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)

Third CECOG consensus on the systemic treatment of non-small-cell lung cancer

Second consensus on medical treatment of metastatic breast cancer

48. MicroRNA prognostic signature for distant relapse in early stage colon cancer

3099 Phase 3 trial (NGR015) of best investigator choice (BIC) with or without NGR-hTNF in previously treated malignant pleural mesothelioma (MPM)

484 Germline Variants in Angiogenesis Genes as Markers of Progression-free Survival in Stage I-III Non-small Cell Lung Cancer Patients

PO-1324 Body composition as a predictor of an in-field recurrence in stage III NSCLC patients

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

AOSOP6 Results from the 2-year open-label extension treatment phase of a pivotal phase 3 study of denosumab in patients with breast cancer and bone metastases previously treated with zoledronic acid or denosumab

SA 8.4 - Post-mastectomy radiation therapy after breast reconstruction: indication, timing and results

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Phase III trial (EORTC 10994/BIG 00-01) assessing the value of p53 using a functional assay to predict sensitivity to a taxane versus nontaxane primary chemotherapy in breast cancer: Final analysis

Aktive Filter

Suchergebnisse filtern